Related Experiment Videos
Tuberous sclerosis with visceral organ involvement
Summary
Tuberous sclerosis (TS) frequently affects visceral organs, particularly the heart and kidneys. Early detection of these TS manifestations is crucial for managing potential complications and improving patient outcomes.
Area of Science:
- Medical Genetics
- Pediatric Neurology
- Cardiology
Background:
- Tuberous sclerosis (TS) is a genetic disorder characterized by the development of tumors in various organs.
- Visceral organ involvement in TS can lead to significant morbidity, necessitating a thorough understanding of its incidence.
Purpose of the Study:
- To determine the incidence and patterns of visceral organ involvement in a cohort of patients diagnosed with tuberous sclerosis.
- To highlight the most commonly affected visceral organs in TS and their clinical implications.
Main Methods:
- Retrospective review of 30 patients diagnosed with tuberous sclerosis between 1987 and 1997.
- Analysis of medical records to identify and document visceral organ involvement, including cardiac, renal, and retinal manifestations.
Main Results:
- The study reviewed 30 TS cases (17 males, 13 females; ages 1 day to 17 years).
- Most common manifestations included seizures (25), skin issues (25), and cerebral tubercles (24).
- Visceral organ involvement was observed in the heart (10 cases; 9 rhabdomyoma, 1 cardiomyopathy), kidneys (4 cases; 3 polycystic kidney disease, 1 hamartoma), and retina (3 cases; astrocytic hamartoma).
- Heart and kidney involvement were the most frequent visceral complications.
- Cardiac rhabdomyomas were prevalent in infants under one year old.
- No mortality was recorded among patients with visceral organ involvement during the study period.
Conclusions:
- Visceral organ involvement, especially of the heart and kidneys, is a significant concern in tuberous sclerosis management.
- Clinicians should maintain a high index of suspicion for cardiac and renal abnormalities in TS patients.
- Prompt recognition and management of visceral TS manifestations are essential to prevent severe morbidity.